UPMC CancerCenter
Hospitals and Health CarePennsylvania, United States51-200 Employees
UPMC CancerCenter provides cancer treatment for common and rare cancers with fourteen specialized programs staffed by recognized cancer care specialists.
Specialized Cancer Care UPMC CancerCenter offers highly specialized cancer treatments across multiple programs, indicating a potential demand for advanced medical technology, research tools, and support services tailored for oncology care providers.
Mid-Sized Scale With a team of 51-200 employees and annual revenues between 25 and 50 million dollars, UPMC CancerCenter presents a substantial but targeted market opportunity for solutions that enhance operational efficiency and patient outcomes without the complexities of larger institutions.
Growth Potential As part of the competitive landscape alongside major players like Memorial Sloan Kettering and MD Anderson, UPMC CancerCenter may seek innovative collaborations to expand its capacity or improve treatments, making it open to new innovations in healthcare technology and services.
Regional Focus Located in Pittsburgh, Pennsylvania, UPMC CancerCenter has a strong regional presence that could be leveraged for localized partnerships, community outreach solutions, or telehealth services to broaden its patient reach.
Digital and Tech Adoption The emphasis on a modern tech stack and ongoing updates suggests a readiness to integrate advanced healthcare IT solutions, telemedicine, and data analytics to improve treatment personalization and operational management.
| UPMC CancerCenter Email Formats | Percentage |
| LastF@upmc.edu | 63% |
| First.Last@upmc.edu | 30% |
| FirstL@upmc.edu | 4% |
| LastFi@upmc.edu | 3% |
Hospitals and Health CarePennsylvania, United States51-200 Employees
UPMC CancerCenter provides cancer treatment for common and rare cancers with fourteen specialized programs staffed by recognized cancer care specialists.
UPMC CancerCenter's revenue is estimated to be in the range of $25M$50M
UPMC CancerCenter's revenue is estimated to be in the range of $25M$50M